• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimizing Clinical Trial Design for Patients with Non-muscle-invasive Bladder Cancer.

作者信息

Weinstock Chana, Agrawal Sundeep, Chang Elaine

机构信息

Department of Oncology, United States Food and Drug Administration, Silver Spring, MD, USA.

Department of Oncology, United States Food and Drug Administration, Silver Spring, MD, USA.

出版信息

Eur Urol. 2022 Jul;82(1):47-48. doi: 10.1016/j.eururo.2022.02.014. Epub 2022 Mar 15.

DOI:10.1016/j.eururo.2022.02.014
PMID:35304001
Abstract
摘要

相似文献

1
Optimizing Clinical Trial Design for Patients with Non-muscle-invasive Bladder Cancer.优化非肌层浸润性膀胱癌患者的临床试验设计
Eur Urol. 2022 Jul;82(1):47-48. doi: 10.1016/j.eururo.2022.02.014. Epub 2022 Mar 15.
2
Endpoints of clinical trials for muscle-invasive bladder cancer.肌肉浸润性膀胱癌临床试验的终点
Prog Clin Biol Res. 1990;353:65-74.
3
Endpoints of clinical trials in invasive bladder cancer.浸润性膀胱癌临床试验的终点
Semin Oncol. 1990 Oct;17(5):619-27.
4
Current Clinical Trials in Non-muscle Invasive Bladder Cancer.非肌肉浸润性膀胱癌的当前临床试验
Curr Urol Rep. 2018 Oct 24;19(12):101. doi: 10.1007/s11934-018-0852-6.
5
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group.肌肉浸润性和转移性尿路上皮癌当代临床研究的批判性分析：膀胱癌倡导网络临床试验工作组的报告。
Cancer. 2013 Jun 1;119(11):1994-8. doi: 10.1002/cncr.27973. Epub 2013 Mar 1.
6
Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial Design.卡介苗治疗非肌肉浸润性膀胱癌患者的当代结局：对临床试验设计的启示。
J Urol. 2021 Jun;205(6):1612-1621. doi: 10.1097/JU.0000000000001633. Epub 2021 Jan 27.
7
Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trial.肌层浸润性膀胱癌的围手术期化疗：MAGNOLIA 试验研究概述及替代辅助治疗的未满足临床需求。
Eur Urol. 2014 Mar;65(3):509-11. doi: 10.1016/j.eururo.2013.10.056. Epub 2013 Nov 11.
8
Identifying risk factors in patients with non-muscle-invasive bladder cancer: clinical implications.非肌层浸润性膀胱癌患者危险因素的识别：临床意义
Eur Urol. 2011 Oct;60(4):721-3. doi: 10.1016/j.eururo.2011.07.065. Epub 2011 Aug 5.
9
[Study for the treatment of nonmuscle invasive bladder cancer : A phase III efficacy trial for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) - AB 40/11 of the AUO].[非肌层浸润性膀胱癌的治疗研究：欧洲泌尿外科学会（AUO）AB 40/11研究中，槲寄生提取物膀胱灌注治疗浅表性膀胱癌的III期疗效试验（TIM）]
Urologe A. 2016 Jul;55(7):963-5. doi: 10.1007/s00120-016-0135-0.
10
Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial.新辅助顺铂、甲氨蝶呤和长春碱化疗用于肌层浸润性膀胱癌：一项随机对照试验。
J Urol. 2000 May;163(5):1602-3.

引用本文的文献

1
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.美国国家癌症研究所（NCI）关于非肌层浸润性膀胱癌下一代临床试验规划会议总结。
Bladder Cancer. 2025 Feb 24;11(1):23523735251319185. doi: 10.1177/23523735251319185. eCollection 2025 Jan-Mar.
2
USP20 mediates malignant phenotypic changes in bladder cancer through direct interactions with YAP1.USP20通过与YAP1直接相互作用介导膀胱癌的恶性表型变化。
Neoplasia. 2025 Feb;60:101102. doi: 10.1016/j.neo.2024.101102. Epub 2024 Dec 13.
3
Robot-assisted, laparoscopic and open radical cystectomy for bladder cancer: A systematic review and network meta-analysis.
机器人辅助腹腔镜与开放性根治性膀胱切除术治疗膀胱癌：系统评价和网络荟萃分析。
Int Braz J Urol. 2024 Nov-Dec;50(6):683-702. doi: 10.1590/S1677-5538.IBJU.2024.0191.
4
Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment.甲硫氨酸协调顺铂耐药膀胱癌微环境中的代谢脆弱性。
Cell Death Dis. 2023 Aug 15;14(8):525. doi: 10.1038/s41419-023-06050-1.
5
The Management of Bacillus Calmette-Guérin (BCG) Failure in High-Risk Non-muscle Invasive Bladder Cancer: A Review Article.高危非肌层浸润性膀胱癌中卡介苗（BCG）治疗失败的管理：一篇综述文章
Cureus. 2023 Jun 26;15(6):e40962. doi: 10.7759/cureus.40962. eCollection 2023 Jun.
6
Applications of Exosomes in Diagnosing Muscle Invasive Bladder Cancer.外泌体在肌肉浸润性膀胱癌诊断中的应用
Pharmaceutics. 2022 Sep 23;14(10):2027. doi: 10.3390/pharmaceutics14102027.